Hyang-Sook Hoe Selected Research

Neurodegenerative Diseases (Neurodegenerative Disease)

1/2021	Emerging pathogenic role of peripheral blood factors following BBB disruption in neurodegenerative disease.
1/2020	The MAO Inhibitor Tranylcypromine Alters LPS- and Aβ-Mediated Neuroinflammatory Responses in Wild-type Mice and a Mouse Model of AD.
5/2013	A tetra(ethylene glycol) derivative of benzothiazole aniline enhances Ras-mediated spinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hyang-Sook Hoe Research Topics

Disease

32	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 04/2005
10	Neuroinflammatory Diseases 01/2022 - 01/2018
8	Neoplasms (Cancer) 01/2020 - 02/2017
4	Cognitive Dysfunction 07/2022 - 01/2016
4	Gliosis 01/2022 - 03/2010
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 05/2013
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2022 - 10/2019
2	Amyloid Plaque 01/2019 - 12/2009
2	Neoplasm Metastasis (Metastasis) 01/2018 - 09/2017
2	Glioma (Gliomas) 12/2017 - 12/2017
1	Tauopathies 09/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Hypertrophy 01/2021
1	Inflammation (Inflammations) 01/2021
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2020
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2018
1	Osteosarcoma (Osteogenic Sarcoma) 09/2017
1	Lung Neoplasms (Lung Cancer) 02/2017
1	Hypertension (High Blood Pressure) 10/2013
1	Substance-Related Disorders (Drug Abuse) 01/2013
1	Memory Disorders (Memory Loss) 01/2012
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2011
1	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2011
1	Encephalitis (Encephalitis, Rasmussen) 09/2010
1	Edema (Dropsy) 09/2010
1	Chronic Brain Injury 12/2009
1	Neuroblastoma 11/2008

Drug/Important Bio-Agent (IBA)

13	Amyloid (Amyloid Fibrils)IBA 01/2019 - 10/2007
12	Proteins (Proteins, Gene)FDA Link 07/2022 - 04/2005
7	Pharmaceutical PreparationsIBA 01/2021 - 01/2018
6	Amyloid beta-PeptidesIBA 01/2022 - 04/2005
6	Apolipoproteins E (ApoE)IBA 11/2015 - 04/2005
5	ApolipoproteinsIBA 11/2015 - 04/2005
4	CytokinesIBA 01/2022 - 09/2010
3	InflammasomesIBA 01/2022 - 01/2021
3	Phosphotransferases (Kinase)IBA 01/2021 - 03/2010
2	idebenoneIBA 01/2022 - 09/2021
2	Interleukin-6 (Interleukin 6)IBA 09/2021 - 01/2021
2	ibrutinibIBA 01/2021 - 09/2018
2	Dasatinib (BMS 354825)FDA Link 01/2020 - 10/2019
2	Flavin-Adenine Dinucleotide (FAD)IBA 01/2019 - 08/2015
2	ascochlorinIBA 01/2018 - 01/2018
2	Histone Deacetylase InhibitorsIBA 12/2017 - 01/2013
2	Matrix Metalloproteinases (MMPs)IBA 12/2017 - 09/2017
2	CholesterolIBA 06/2012 - 10/2007
1	nilotinib FDA Link 07/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2022
1	Neuroprotective AgentsIBA 01/2022
1	Caspase 1 (ICE Protease)IBA 01/2022
1	Rivastigmine (Exelon)FDA LinkGeneric 09/2021
1	Donepezil (Aricept)FDA LinkGeneric 09/2021
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 09/2021
1	Complement C8 (C8 Complement)IBA 01/2021
1	gliquidoneIBA 01/2021
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Tranylcypromine (Parnate)FDA LinkGeneric 01/2020
1	Monoamine Oxidase (MAO)IBA 01/2020
1	masitinibIBA 01/2020
1	regorafenibIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Antidepressive Agents (Antidepressants)IBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2018
1	Janus KinasesIBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Terpenes (Terpenoids)IBA 01/2018
1	phorbolIBA 12/2017
1	Antineoplastic Agents (Antineoplastics)IBA 12/2017
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 09/2017
1	GlucosinolatesIBA 09/2017
1	phenethyl isothiocyanate (PEITC)IBA 09/2017
1	IsothiocyanatesIBA 09/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2017
1	delphinidinIBA 02/2017
1	benzothiazoleIBA 02/2014
1	Ethylene Glycol (Monoethylene Glycol)IBA 02/2014
1	aniline (aniline hydrobromide)IBA 02/2014
1	Antihypertensive Agents (Antihypertensives)IBA 10/2013
1	Valsartan (Vals)FDA Link 10/2013
1	Matrix Metalloproteinase InhibitorsIBA 01/2013
1	Presenilin-1IBA 04/2012
1	CaspasesIBA 06/2011
1	Neurotransmitter Agents (Neurotransmitter)IBA 06/2011
1	AntibodiesIBA 09/2010
1	amyloid beta-protein (1-42)IBA 03/2010
1	Protein Isoforms (Isoforms)IBA 12/2009
1	Peptides (Polypeptides)IBA 03/2009
1	tarenflurbilIBA 11/2008
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2008
1	Tissue Inhibitor of Metalloproteinase-3IBA 10/2007
1	Glycogen Synthase Kinase 3 betaIBA 12/2006

Therapy/Procedure

4	Therapeutics 01/2020 - 05/2013